Recent Articles from TheStreet

Zoominfo Lead

Five Top Stock Gainers for Tuesday: Under Armour, ZoomInfo, Translate Bio

Under Armour, ZoomInfo, Translate Bio, Outlook Therapeutics and Arcturus Therapeutics are five top gainers for Tuesday.

Stocks Close Higher as Wall Street Dissects New Tax Laws

S&P Closes at Record High as Earnings Outweigh Worries About COVID and China's Clampdown

Stocks end higher as solid earnings reports outweigh jitters about the spread of COVID-19's delta variant and China's clampdown on its gaming and technology sectors

TheStreet Live with Jim Cramer 7/7/21

Stock Market Today With Jim Cramer: Is Clorox Yield Enough for Investors?

Clorox had a rough second quarter and Jim Cramer says big changes are needed at the consumer-products company.

SpaceX Lead

Musk's SpaceX Wins Round in Texas Land Dispute

SpaceX wins a round in a case involving property being used to support a rocket launch facility in Texas, a media report says.

McDonald's Lead

McDonald's and FaZe Clan Partner to Promote FaZe With Videos

FaZe formed a partnership with McDonald's, 'anchored by a series of dynamic content activations centered around diversity and inclusion.'

Under Armour Lead

Here's How to Trade Under Armour After Earnings Beat

Under Armour stock is rising after the company reported better-than-expected earnings.

Microsoft Names Qualcomm Executive Hou Yang As New Greater China Chief

Microsoft to Require Proof of Vaccination for U.S. Office Entry

Microsoft will require employees to show proof they are vaccinated against COVID-19 before they can enter any company facility in the U.S.

Jim Cramer: How Robinhood Turned E*Trade Into a Dinosaur

Robinhood Stock Jumps, Exceeds IPO Price of $38

Robinhood stock jumped double digits on Tuesday, exceeding its IPO price of $38.

Nvidia Lead

Nvidia Stock Flat as U.K. Reportedly Might Block Arm Deal

An assessment of Nvidia's acquisition of Arm contains implications for U.K. national security, a media report says.

Alibaba Lead

Alibaba Stock Needs to Reclaim This Level of Support After Earnings

Alibaba stock desperately needs to reclaim a key level of support, but so far it hasn't been able to. Let's look at the charts.